- Bevorzugter Name
- N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
- IUPAC
- N-[(3R,4S)-1-benzyl-4-methylpiperidin-3-yl]-N-methyl-7-(4-methylphenyl)sulfonylpyrrolo[2,3-d]pyrimidin-4-amine
- Englischer Name
- Tofacitinib Impurity 20
- Summenformel
- C27H31N5O2S
- Molmasse
- 489.63
Namen und Synonyme
N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine1092578-44-3Tofacitinib Impurity AN-(TRANS-1-BENZYL-4-METHYLPIPERIDIN-3-YL)-N-METHYL-7-TOSYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINECS-0166067F82045N-((3R,4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity pound(c)Rel-N-((3R,4S)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amineTofatinib Impurity 20Tofacitinib Impurity 134N-((3R,4S)-1-Benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine (Tofacitinib Impurity)7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3R,4S)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7-[(4-methylphenyl)sulfonyl]-